StockData
Evolent Health, Inc. logo

Evolent Health, Inc. (EVH) stock

EVHNYSEServices-Management ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3065% below fair value
$3.93−0.69 (-14.94%)

Close on Nov 18, 2026Market cap $444.32MP/E –Yield –

Evolent Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Evolent Health's operating income for the twelve months ending Jun 30, 2026 was -$427.51M. For fiscal 2025 it was -$410.14M. The highest annual figure on record is $3.64M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$410.14M–
FY2024Dec 31, 2024-$40.49M–
FY2023Dec 31, 2023-$71.21M-2055.3%
FY2022Dec 31, 2022$3.64M–
FY2021Dec 31, 2021-$42.41M–
FY2020Dec 31, 2020-$262.85M–
FY2019Dec 31, 2019-$308.89M–
FY2018Dec 31, 2018-$47.48M–
FY2017Dec 31, 2017-$72.84M–
FY2016Dec 31, 2016-$237.42M–
FY2015Dec 31, 2015-$42.97M–
FY2014Dec 31, 2014$0–
FY2013Dec 31, 2013-$21.16M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.56M–
Q1 FY2026Mar 31, 2026-$10.60M–
Q4 FY2025Dec 31, 2025-$408.23M–
Q3 FY2025Sep 30, 2025$886.00K–
Q2 FY2025Jun 30, 2025-$1.17M-115.0%
Q1 FY2025Mar 31, 2025-$1.62M–
Q4 FY2024Dec 31, 2024-$18.60M–
Q3 FY2024Sep 30, 2024-$16.27M–
Q2 FY2024Jun 30, 2024$7.79M–
Q1 FY2024Mar 31, 2024-$13.41M–
Q4 FY2023Dec 31, 2023-$21.35M–
Q3 FY2023Sep 30, 2023-$17.94M-238.5%
Q2 FY2023Jun 30, 2023-$21.57M–
Q1 FY2023Mar 31, 2023-$10.36M–
Q4 FY2022Dec 31, 2022-$1.88M–
Q3 FY2022Sep 30, 2022$12.95M–
Q2 FY2022Jun 30, 2022-$4.63M–
Q1 FY2022Mar 31, 2022-$2.80M–
Q4 FY2021Dec 31, 2021-$12.21M-370.2%
Q3 FY2021Sep 30, 2021-$6.58M–
Q2 FY2021Jun 30, 2021-$7.67M–
Q1 FY2021Mar 31, 2021-$15.95M–
Q4 FY2020Dec 31, 2020$4.52M–
Q3 FY2020Sep 30, 2020-$16.45M–
Q2 FY2020Jun 30, 2020-$225.83M–
Q1 FY2020Mar 31, 2020-$25.09M–
Q4 FY2019Dec 31, 2019-$216.87M–
Q3 FY2019Sep 30, 2019-$20.14M–
Q2 FY2019Jun 30, 2019-$25.23M–
Q1 FY2019Mar 31, 2019-$46.65M–
Q4 FY2018Dec 31, 2018-$13.35M–
Q3 FY2018Sep 30, 2018-$11.03M–
Q2 FY2018Jun 30, 2018-$8.97M–
Q1 FY2018Mar 31, 2018-$14.13M–
Q4 FY2017Dec 31, 2017-$18.25M–
Q3 FY2017Sep 30, 2017-$14.02M–
Q2 FY2017Jun 30, 2017-$19.12M–
Q1 FY2017Mar 31, 2017-$21.46M–
Q4 FY2016Dec 31, 2016-$33.87M–
Q3 FY2016Sep 30, 2016-$15.84M–

More Evolent Health figures

See a number that looks wrong?